Skip to main content
Top
Published in: Clinical Rheumatology 9/2017

Open Access 01-09-2017 | Original Article

Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control

Authors: Daniel E. Furst, Melody Tran, Emma Sullivan, James Pike, James Piercy, Vivian Herrera, Jacqueline B. Palmer

Published in: Clinical Rheumatology | Issue 9/2017

Login to get access

Abstract

The main objective of the present study is to evaluate the misalignment between psoriatic arthritis (PsA) patient- and physician-reported satisfaction with PsA control. Data came from the Adelphi Rheumatology Disease Specific Programme, a retrospective, cross-sectional survey of US-based rheumatologists and patients. Physicians provided satisfaction and clinical characteristics on tender joint count, swollen joint count, and percent body surface area (BSA) affected by psoriasis. Patients provided data on satisfaction, the Work Productivity Activity Impairment and Health Assessment Questionnaire-Disability Index (HAQ-DI) questionnaires. Based on their satisfaction response, patient-physician pairs were classified into aligned (both satisfied or dissatisfied) or misaligned (rated satisfaction differently) groups. Multivariate analysis evaluated association of characteristics with misalignment. Among 305 paired patient-physician records analyzed, 23.6% were misaligned and 76.4% were aligned. The misaligned group had shorter disease duration (mean years, 5.2 vs. 6.4), used fewer biologic disease-modifying antirheumatic drugs (49.3 vs. 62.9%), had more swollen (mean, 3.7 vs. 1.9, P = 0.0002) and tender joints (mean, 5.6 vs. 2.9, P < 0.0001), greater proportion of patients with comorbidities (72.2 vs. 63.1%), and >3% BSA affected by psoriatic skin lesions (64.2 vs. 55.1%). Misaligned patients reported greater work impairment (mean, 38.7 vs. 21.4, P = 0.0004), daily activities (mean, 38.7 vs. 22.3, P < 0.0001), and higher disease burden (mean HAQ-DI; 0.56 vs. 0.37, P = 0.0001). Multivariate analysis found the number of swollen joints (P = 0.02) and HAQ-DI score (P = 0.03) was significantly associated with misalignment among all patients; however, not in the subgroup of employed patients. Patient-physician misalignment is associated with increased disease activity and disability among patients with PsA.
Literature
1.
go back to reference Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M et al (2010) Psoriatic arthritis: a systematic review. Int J Rheum Dis 13:300–317CrossRefPubMed Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M et al (2010) Psoriatic arthritis: a systematic review. Int J Rheum Dis 13:300–317CrossRefPubMed
2.
go back to reference Lee S, Mendelsohn A, Sarnes E (2010) The burden of psoriatic arthritis: a literature review from a global health systems perspective. P T 35:680–689PubMedPubMedCentral Lee S, Mendelsohn A, Sarnes E (2010) The burden of psoriatic arthritis: a literature review from a global health systems perspective. P T 35:680–689PubMedPubMedCentral
3.
go back to reference American Academy of Dermatology Work, G, Menter A, Korman NJ, Elmets CA, Feldman SR et al (2011) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 65:137–174CrossRef American Academy of Dermatology Work, G, Menter A, Korman NJ, Elmets CA, Feldman SR et al (2011) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 65:137–174CrossRef
4.
go back to reference Lewin, SA, Skea, ZC, Entwistle, V, Zwarenstein, M, Dick, J (2001) Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev (4):CD003267. doi:10.1002/14651858.CD003267 Lewin, SA, Skea, ZC, Entwistle, V, Zwarenstein, M, Dick, J (2001) Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev (4):CD003267. doi:10.​1002/​14651858.​CD003267
5.
go back to reference Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P et al (2009) Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 68:1387–1394CrossRefPubMed Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P et al (2009) Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 68:1387–1394CrossRefPubMed
6.
go back to reference Coates LC, Ritchlin CT, Kavanaugh AF (2014) GRAPPA treatment recommendations: an update from the GRAPPA 2013 annual meeting. J Rheumatol 41:1237–1239CrossRefPubMed Coates LC, Ritchlin CT, Kavanaugh AF (2014) GRAPPA treatment recommendations: an update from the GRAPPA 2013 annual meeting. J Rheumatol 41:1237–1239CrossRefPubMed
7.
go back to reference Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M et al (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75:499–510CrossRefPubMed Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M et al (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75:499–510CrossRefPubMed
8.
go back to reference Ramiro S, Smolen JS, Landewe R, van der Heijde D, Dougados M et al (2016) Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis 75:490–498CrossRefPubMed Ramiro S, Smolen JS, Landewe R, van der Heijde D, Dougados M et al (2016) Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis 75:490–498CrossRefPubMed
9.
go back to reference Rohekar S, Chan J, Tse SM, Haroon N, Chandran V et al (2015) 2014 update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in Canada J Rheumatol 42:654–664PubMed Rohekar S, Chan J, Tse SM, Haroon N, Chandran V et al (2015) 2014 update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in Canada J Rheumatol 42:654–664PubMed
10.
go back to reference Coates LC, Tillett W, Chandler D, Helliwell PS, Korendowych E et al (2013) The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology (Oxford) 52:1754–1757CrossRef Coates LC, Tillett W, Chandler D, Helliwell PS, Korendowych E et al (2013) The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology (Oxford) 52:1754–1757CrossRef
11.
go back to reference Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD (2015) Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care Res (Hoboken) 67:264–272CrossRef Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD (2015) Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care Res (Hoboken) 67:264–272CrossRef
12.
go back to reference Kavanaugh A, Cassell S (2005) The assessment of disease activity and outcomes in psoriatic arthritis. Clin Exp Rheumatol 23(5 Suppl 39):S142–S147PubMed Kavanaugh A, Cassell S (2005) The assessment of disease activity and outcomes in psoriatic arthritis. Clin Exp Rheumatol 23(5 Suppl 39):S142–S147PubMed
13.
go back to reference Selzer RM, Ellen S, McGartland M (2013) Alignment: a conceptual shift from adherence. Intern Med J 43:940–942CrossRefPubMed Selzer RM, Ellen S, McGartland M (2013) Alignment: a conceptual shift from adherence. Intern Med J 43:940–942CrossRefPubMed
14.
go back to reference Coates LC, Navarro-Coy N, Brown SR, Brown S, McParland L et al (2013) The TICOPA protocol (TIght COntrol of psoriatic arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskelet Disord 14:101CrossRefPubMedPubMedCentral Coates LC, Navarro-Coy N, Brown SR, Brown S, McParland L et al (2013) The TICOPA protocol (TIght COntrol of psoriatic arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskelet Disord 14:101CrossRefPubMedPubMedCentral
15.
go back to reference Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG et al (2013) The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 72:986–991CrossRefPubMed Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG et al (2013) The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 72:986–991CrossRefPubMed
16.
17.
go back to reference Gladman DD, Landewe R, McHugh NJ, Fitzgerald O, Thaci D et al (2010) Composite measures in psoriatic arthritis: GRAPPA 2008. J Rheumatol 37:453–461CrossRefPubMed Gladman DD, Landewe R, McHugh NJ, Fitzgerald O, Thaci D et al (2010) Composite measures in psoriatic arthritis: GRAPPA 2008. J Rheumatol 37:453–461CrossRefPubMed
18.
go back to reference Dandorfer SW, Rech J, Manger B, Schett G, Englbrecht M (2012) Differences in the patient’s and the physician’s perspective of disease in psoriatic arthritis. Semin Arthritis Rheum 42:32–41CrossRefPubMed Dandorfer SW, Rech J, Manger B, Schett G, Englbrecht M (2012) Differences in the patient’s and the physician’s perspective of disease in psoriatic arthritis. Semin Arthritis Rheum 42:32–41CrossRefPubMed
19.
go back to reference Chaudhry SR, Thavaneswaran A, Chandran V, Gladman DD (2013) Physician scores vs patient self-report of joint and skin manifestations in psoriatic arthritis. Rheumatology (Oxford) 52:705–711CrossRef Chaudhry SR, Thavaneswaran A, Chandran V, Gladman DD (2013) Physician scores vs patient self-report of joint and skin manifestations in psoriatic arthritis. Rheumatology (Oxford) 52:705–711CrossRef
20.
go back to reference Leung YY, Tam LS, Lee KW, Leung MH, Kun EW et al (2009) Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis. Rheumatology (Oxford) 48:53–56CrossRef Leung YY, Tam LS, Lee KW, Leung MH, Kun EW et al (2009) Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis. Rheumatology (Oxford) 48:53–56CrossRef
21.
go back to reference Anderson P, Benford M, Harris N, Karavali M, Piercy J (2008) Real-world physician and patient behaviour across countries: Disease-Specific Programmes—a means to understand. Curr Med Res Opin 24:3063–3072CrossRefPubMed Anderson P, Benford M, Harris N, Karavali M, Piercy J (2008) Real-world physician and patient behaviour across countries: Disease-Specific Programmes—a means to understand. Curr Med Res Opin 24:3063–3072CrossRefPubMed
22.
go back to reference Atzeni F, Cazzola M, Benucci M, Di Franco M, Salaffi F et al (2011) Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol 25:165–171CrossRefPubMed Atzeni F, Cazzola M, Benucci M, Di Franco M, Salaffi F et al (2011) Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol 25:165–171CrossRefPubMed
23.
go back to reference Sokka T, Pincus T (2005) Quantitative joint assessment in rheumatoid arthritis. Clin Exp Rheumatol 23(5 Suppl 39):S58–S62PubMed Sokka T, Pincus T (2005) Quantitative joint assessment in rheumatoid arthritis. Clin Exp Rheumatol 23(5 Suppl 39):S58–S62PubMed
24.
go back to reference Barton JL, Criswell LA, Kaiser R, Chen YH, Schillinger D (2009) Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis. J Rheumatol 36:2635–2641CrossRefPubMedPubMedCentral Barton JL, Criswell LA, Kaiser R, Chen YH, Schillinger D (2009) Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis. J Rheumatol 36:2635–2641CrossRefPubMedPubMedCentral
25.
go back to reference Cleary PD, McNeil BJ (1988) Patient satisfaction as an indicator of quality care. Inquiry 25:25–36PubMed Cleary PD, McNeil BJ (1988) Patient satisfaction as an indicator of quality care. Inquiry 25:25–36PubMed
26.
go back to reference Rosenthal GE, Shannon SE (1997) The use of patient perceptions in the evaluation of health-care delivery systems. Med Care 35(11 Suppl):NS58–NN68PubMed Rosenthal GE, Shannon SE (1997) The use of patient perceptions in the evaluation of health-care delivery systems. Med Care 35(11 Suppl):NS58–NN68PubMed
27.
go back to reference Ciocon DH, Horn EJ, Kimball AB (2008) Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only: results of the 2005 spring US National Psoriasis Foundation Survey. Am J Clin Dermatol 9:111–117CrossRefPubMed Ciocon DH, Horn EJ, Kimball AB (2008) Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only: results of the 2005 spring US National Psoriasis Foundation Survey. Am J Clin Dermatol 9:111–117CrossRefPubMed
28.
go back to reference Lebwohl MG, Kavanaugh A, Armstrong AW, Van Voorhees AS (2016) US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Am J Clin Dermatol 17:87–97CrossRefPubMed Lebwohl MG, Kavanaugh A, Armstrong AW, Van Voorhees AS (2016) US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Am J Clin Dermatol 17:87–97CrossRefPubMed
29.
go back to reference Brekke M, Hjortdahl P, Kvien TK (2001) Self-efficacy and health status in rheumatoid arthritis: a two-year longitudinal observational study. Rheumatology (Oxford) 40:387–392CrossRef Brekke M, Hjortdahl P, Kvien TK (2001) Self-efficacy and health status in rheumatoid arthritis: a two-year longitudinal observational study. Rheumatology (Oxford) 40:387–392CrossRef
30.
go back to reference Nota I, Drossaert CH, Taal E, Vonkeman HE, van de Laar MA (2014) Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey. BMC Musculoskelet Disord 15:333CrossRefPubMedPubMedCentral Nota I, Drossaert CH, Taal E, Vonkeman HE, van de Laar MA (2014) Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey. BMC Musculoskelet Disord 15:333CrossRefPubMedPubMedCentral
31.
go back to reference Barton JL, Imboden J, Graf J, Glidden D, Yelin EH et al (2010) Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken) 62:857–864CrossRef Barton JL, Imboden J, Graf J, Glidden D, Yelin EH et al (2010) Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken) 62:857–864CrossRef
32.
go back to reference Khan NA, Spencer HJ, Abda E, Aggarwal A, Alten R et al (2012) Determinants of discordance in patients’ and physicians’ rating of rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken) 64:206–214CrossRef Khan NA, Spencer HJ, Abda E, Aggarwal A, Alten R et al (2012) Determinants of discordance in patients’ and physicians’ rating of rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken) 64:206–214CrossRef
33.
go back to reference Studenic P, Radner H, Smolen JS, Aletaha D (2012) Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. Arthritis Rheum 64:2814–2823CrossRefPubMed Studenic P, Radner H, Smolen JS, Aletaha D (2012) Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. Arthritis Rheum 64:2814–2823CrossRefPubMed
34.
go back to reference Nicolau G, Yogui MM, Vallochi TL, Gianini RJ, Laurindo IM et al (2004) Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity. J Rheumatol 31:1293–1296PubMed Nicolau G, Yogui MM, Vallochi TL, Gianini RJ, Laurindo IM et al (2004) Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity. J Rheumatol 31:1293–1296PubMed
Metadata
Title
Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control
Authors
Daniel E. Furst
Melody Tran
Emma Sullivan
James Pike
James Piercy
Vivian Herrera
Jacqueline B. Palmer
Publication date
01-09-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3578-9

Other articles of this Issue 9/2017

Clinical Rheumatology 9/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.